Reader response: Progressive multifocal leukoencephalopathy after fingolimod treatment.

@article{Lalive2019ReaderRP,
  title={Reader response: Progressive multifocal leukoencephalopathy after fingolimod treatment.},
  author={Patrice H Lalive and Serge Roth and Renaud Du Pasquier},
  journal={Neurology},
  year={2019},
  volume={92 3},
  pages={
          151
        }
}
  • Patrice H Lalive, Serge Roth, Renaud Du Pasquier
  • Published in Neurology 2019
  • Medicine
  • Berger et al.,1 based on the Novartis safety data lock point of August 31, 2017, reported that the risk of patients developing progressive multifocal leukoencephalopathy (PML) after treatment with fingolimod remains low. Addressing the question of PML risk is of particular importance in light of the recent increase of fingolimod-treated patients with this devastating iatrogenic complication. Nevertheless, the results presented here are lacking, mostly because the risk calculation is made with… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv